Varian Medical Systems and ScandiDos Partner for Worldwide Radiotherapy Distribution

(Palo Alto, CA, USA) and ScandiDos, AB (Uppsala, Sweden) reported that the companies have signed a nonexclusive distributor agreement. The agreement covers the ScandiDos Delta4PT pretreatment verification system, for use with Varian's RapidArc radiotherapy technology, the TrueBeam system, and Varian's technology for intensity-modulated radiation therapy (IMRT).

The agreement allows Varian and its affiliates worldwide to offer Delta4PT to their customers, providing additional solutions for fast and accurate verification of complex radiation-therapy technologies.

ScandiDos Delta4PT QA system is a quality assurance (QA) tool used to assess radiotherapy treatment plans to help insure that they will result in the desired dose distribution before actual treatments commence. It allows the users to rapidly verify and approve the delivery of complex radiotherapy treatment plans by simulating treatments and generating real dose measurements in relation to a three-dimensional target volume. Delta4PT has been used in the validation of new treatment techniques such as Varian's RapidArc. Delta4PT has been in clinical use for IMRT and arc therapy QA since 2006 and is used today in clinics worldwide.

"At ScandiDos we are very proud to have Varian, the largest worldwide supplier of radiation therapy systems and developer of new innovative technologies such as TrueBeam and RapidArc, distributing our QA systems. We look forward to continue to offer QA solutions to Varian and its customers with our Delta4 system when implementing new modalities in the future," said Gorgen Nilsson, CEO at ScandiDos.

ScandiDos' goal is to provide complete dosimetry systems that enable clinics around the world to implement new treatment modalities satisfying the demand on accuracy in dose verification and patient throughput.

Related Links:
Varian Medical Systems
ScandiDos